Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Interview: Takeda Pharmaceutical CEO Talks Shire Deal, Shifting Business Structure – Part 1

Filed Under: Interviews Tagged With: , , , , ,

Takeda Pharmaceutical Co. Ltd. (TYO:4502) is bringing Irish-based drug manufacturer Shire PLC under its umbrella. Entailing an acquisition price of…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Concerns Arise for Pharmaceutical Supply Chain Amid Crisis in Ukraine
Concerns Arise for Pharmaceutical Supply Chain Amid Crisis…
Interview: Teijin President Jun Suzuki Shines Light on Business Prospects
Interview: Teijin President Jun Suzuki Shines Light on…
Coronavirus Report – Part 33: Japan Eyes Development of Five Potential Treatments
Coronavirus Report – Part 33: Japan Eyes Development of Five…
Coronavirus Report – Part 24: Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures
Coronavirus Report – Part 24: Survey Reveals 12 Japanese…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…